rofecoxib has been researched along with Arthritis, Juvenile Chronic in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We know from adult randomised controlled trials that some NSAIDs, such as ibuprofen, naproxen, and aspirin, can be effective in certain chronic pain conditions." | 4.95 | Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents. ( Anderson, B; Cooper, TE; Eccleston, C; Fisher, E; Wilkinson, NM, 2017) |
| "Both rofecoxib doses were not inferior to naproxen." | 2.72 | Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension. ( Adelsberg, JV; Bolognese, JA; Cavanaugh, P; Chen, PY; Giannini, EH; Goodman, S; Kiss, MH; Lovell, DJ; Reicin, AS; Reiff, A; Zavaler, MF, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eccleston, C | 1 |
| Cooper, TE | 1 |
| Fisher, E | 1 |
| Anderson, B | 1 |
| Wilkinson, NM | 1 |
| Reiff, A | 1 |
| Lovell, DJ | 1 |
| Adelsberg, JV | 1 |
| Kiss, MH | 1 |
| Goodman, S | 1 |
| Zavaler, MF | 1 |
| Chen, PY | 1 |
| Bolognese, JA | 1 |
| Cavanaugh, P | 1 |
| Reicin, AS | 1 |
| Giannini, EH | 1 |
1 review available for rofecoxib and Arthritis, Juvenile Chronic
| Article | Year |
|---|---|
Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Arthritis, Rheumatoid; Asp | 2017 |
1 trial available for rofecoxib and Arthritis, Juvenile Chronic
| Article | Year |
|---|---|
Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension.
Topics: Adolescent; Arthritis, Juvenile; Child; Child, Preschool; Cyclooxygenase 2 Inhibitors; Cyclooxygenas | 2006 |